NUFARM LIMITED — Director's Dealing 2009

Jul 2, 2009

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity NUFARM LIMITED ABN 37 091 323 312

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	WILLIAM BRUCE GOODFELLOW
Date of last notice	12/05/09

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(includingregisteredholder)Note: Provide details of the circumstancesgiving rise to the relevant interest.	Auckland Medical Research Foundation (AMRF) – DrGoodfellow has no beneficial interest in securities held byARMF.
Date of change	13/05/09
No. of securities held priorto change	Direct72,361 Fully Paid Ordinary SharesIndirect:Pacific Custodians Pty Ltd – 39,968 Fully Paid OrdinarySharesMA Goodfellow - 12,177 Fully Paid Ordinary Shares and100 NSSSt Kentigern Trust - 430,186 Fully Paid Ordinary Shares and19,727 NSSSulkem Company Ltd – 117,628 Fully Paid Ordinary SharesAuckland Medical Research Foundation - 25,462 NSSTrustee of theGoodfellowFoundation –35,698FullyPaid

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

		Ordinary Shares and 1,338 NSS.
Class	Ordinary
Number acquired	Indirect – 1,096 Nufarm Step-up Securities (NSS) issued by
	Nufarm Finance (NZ) Ltd
Number disposed	Nil
Value/Consideration	$ 71.85 per NSS
Note: If consideration is non-cash, provide
details and estimated valuation
No. of securities held after	Direct:
change		72,361 Fully Paid Ordinary Shares
	Indirect:
		Pacific Custodians Pty Ltd – 39,968 Fully Paid Ordinary
		Shares
		MA Goodfellow - 12,177 Fully Paid Ordinary Shares and
		100 NSS
		St Kentigern Trust - 430,186 Fully Paid Ordinary Shares and
		19,727 NSS
		Sulkem Company Ltd – 117,628 Fully Paid Ordinary Shares
		Auckland Medical Research Foundation – 26,558 NSS
		Trustees of The Goodfellow Foundation - 35,698 Fully Paid
		Ordinary Shares and 1,338 NSS
Nature of change
Example:on-market trade, off-markettrade, exercise of options, issue of	On	market trade
securities under dividend reinvestment
plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002